May 24 |
Eli Lilly to Invest Another $5.3 Billion in Indiana Manufacturing Site
|
May 24 |
Ether ETF approved, Live Nation antitrust suit: Morning Brief
|
May 24 |
Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro
|
May 24 |
Eli Lilly to spend another $5.3B on production site for Mounjaro, Zepbound
|
May 24 |
Stocks open in the green, Dow hopeful to claw back losses
|
May 24 |
Lilly invests further $5.3 billion in new Indiana site as obesity drug demand soars
|
May 24 |
Lilly Increases Manufacturing Investment to $9 Billion at Newest Indiana Site to Boost API Production for Tirzepatide and Pipeline Medicines
|
May 24 |
Pharma Stock Roundup: AZN's 2030 Sales Target, PFE's New Cost Cut Plan & More
|
May 24 |
Eli Lilly to Spend $5.3 Billion to Make More Mounjaro, Zepbound
|
May 24 |
Jim Cramer Says This Basic Materials Stock Is 'Too Dicey,' Shares His Take On Arista Networks
|